Literature DB >> 21119260

Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation.

Hoon Yub Kim1, Woo Sang Ryu, Sang Uk Woo, Gil Soo Son, Eun Sook Lee, Jae Bok Lee, Jeoung Won Bae.   

Abstract

Radiofrequency ablation (RFA) recently has been applied to benign thyroid nodules, mainly for the cosmetic reasons, and limited cases of local recurrences or focal distant metastases of well-differentiated thyroid cancer, in the high-risk reoperative condition or for the palliative purpose. But no report has been made on the RFA for primary thyroid cancer to date. We report on a patient with primary papillary carcinoma of thyroid gland who had undergone RFA before the cytological diagnosis of malignancy, later referred and treated with robotic surgery successfully. We can learn the following lessons from our case; (1) the RFA for operable primary thyroid malignancy should be avoided, because of the possibility of remnant viable cancer and undetectable nodal metastasis, and (2) robotic or endoscopic thyroid surgery may be a feasible operative method for benign or malignant thyroid nodules previously treated with RFA.

Entities:  

Mesh:

Year:  2010        PMID: 21119260     DOI: 10.4103/0973-1482.73328

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  11 in total

1.  Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: Preliminary results.

Authors:  Wei Zhou; Shan Jiang; Weiwei Zhan; Jianqiao Zhou; Shangyan Xu; Lu Zhang
Journal:  Eur Radiol       Date:  2016-11-16       Impact factor: 5.315

2.  Needle track tumor seeding after radiofrequency ablation of a thyroid tumor.

Authors:  Chang Un Lee; Soo Jin Kim; Jin Yong Sung; Sung Hee Park; Semin Chong; Jung Hwan Baek
Journal:  Jpn J Radiol       Date:  2014-08-19       Impact factor: 2.374

Review 3.  Radiofrequency ablation for benign thyroid nodules.

Authors:  S Bernardi; F Stacul; M Zecchin; C Dobrinja; F Zanconati; B Fabris
Journal:  J Endocrinol Invest       Date:  2016-04-20       Impact factor: 4.256

4.  Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis.

Authors:  Se Jin Cho; Sun Mi Baek; Dong Gyu Na; Kang Dae Lee; Young Kee Shong; Jung Hwan Baek
Journal:  Eur Radiol       Date:  2021-03-13       Impact factor: 5.315

Review 5.  Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy.

Authors:  Sae Rom Chung; Jung Hwan Baek; Young Jun Choi; Jeong Hyun Lee
Journal:  Curr Oncol Rep       Date:  2022-04-06       Impact factor: 5.945

6.  Radiofrequency ablation and thyroid nodules: updated systematic review.

Authors:  Haris Muhammad; Prasanna Santhanam; Jonathon O Russell
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

7.  Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China.

Authors:  Wei Sun; Hao Zhang; Liang He; Ting Zhang; Zhihong Wang; Wenwu Dong; Yingling Jiang
Journal:  Med Sci Monit       Date:  2020-11-22

8.  Residual tumor and central lymph node metastasis after thermal ablation of papillary thyroid carcinoma: A case report and review of literature.

Authors:  Yu Hua; Jia-Wen Yang; Liu He; Hua Xu; Hai-Zhong Huo; Chen-Fang Zhu
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

9.  Combination therapy of temporary tracheal stenting and radiofrequency ablation for multinodular thyroid goiter with airway compression.

Authors:  Ji Hoon Shin; Jung Hwan Baek; Yeon-Mok Oh; Eun Ju Ha; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

Review 10.  Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates.

Authors:  Kai-Pun Wong; Brian Hung-Hin Lang
Journal:  Int J Endocrinol       Date:  2013-11-03       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.